ad

Dr. Lal Pathlabs Ltd. (LALPATHLAB) Share Price Hits Fresh 52-Week High

12 Aug 202610:36 am

Dr. Lal Pathlabs Ltd. (LALPATHLAB) Share Price Hits Fresh 52-Week High

Dr. Lal Pathlabs Ltd. traded at Rs 1,963.95, up 0.75% today, after touching a fresh 52-week high of Rs 1,989.35. Its market capitalisation stood at Rs 32,802.69 crore.

Dr. Lal Pathlabs Ltd. Share Price was at Rs 1,963.95 on 12 August 2026 at 10:17 AM IST, up Rs 14.70 or 0.75% for the day, after the stock touched a fresh 52-week high of Rs 1,989.35. The company’s market capitalisation stood at Rs 32,802.69 crore, making this one-year high notable in today’s market update.

For investors tracking Dr. Lal Pathlabs Ltd. Share Price Today, the verified data confirms a clear price event: the stock moved above its previous close of Rs 1,949.25, opened at Rs 1,950.15, and traded in a narrow intraday band between Rs 1,950.15 and Rs 1,989.35 before easing from the high. Turnover was Rs 1.25 crore on volume of 6,388 shares.

Why is the stock trending? The supplied data confirms the fresh 52-week peak, but it does not establish a company-specific catalyst behind the move. That still makes Dr. Lal Pathlabs Ltd. Stock News relevant because yearly highs often draw attention from investors screening for price strength, relative valuation and sector positioning. Univest notes that the stock’s P/E ratio is 31.07, P/B ratio is 0.45, ROE is -2.89 and ROCE is -0.26, while the Healthcare sector benchmark offers a broader context for comparison. For investors, the next key monitor is whether the stock sustains interest near this 52-week high while its valuation and profitability metrics are assessed against peers and the sector backdrop.

Dr. Lal Pathlabs Ltd. Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,963.95
Previous Close Rs 1,949.25
Today's Change +Rs 14.7 (+0.75%)
Day Open Rs 1,950.15
Fresh 52-Week High Rs 1,989.35
Day Low Rs 1,950.15
Current Volume 6,388
Turnover Rs 1.25 crore
Market Capitalisation Rs 32,802.69 crore

Dr. Lal Pathlabs Ltd. (LALPATHLAB) traded at Rs 1,963.95. versus the previous close of Rs 1,949.25, a rise of 0.75%. The stock opened at Rs 1,950.15, reached Rs 1,989.35, touched Rs 1,950.15. Reported volume was 6,388.

Dr. Lal Pathlabs Ltd. Share Price Today shows a confirmed fresh 52-week high, with the stock rising above the previous close and hitting Rs 1,989.35 in intraday trade. The move was positive but measured, with turnover at Rs 1.25 crore and volume at 6,388 shares, indicating active but not extreme participation in this price event.

The stock opened at Rs 1,950.15 versus the previous close of Rs 1,949.25, signalling a mildly positive start. From there, it moved to an intraday high of Rs 1,989.35, which also became the new 52-week high. The day low was Rs 1,950.15, the same as the opening level, which means the session’s weakest price came right at the start before the stock pushed higher.

At the time of the article, Dr. Lal Pathlabs Ltd. Share Price was at Rs 1,963.95, still above the previous close by Rs 14.70. In percentage terms, that translated into a gain of 0.75%. The difference between the current price and the day high also shows that some intraday cooling followed the touch of the 52-week peak, which is common when a stock enters fresh high territory and short-term traders react to the move.

From a pure price action perspective, this is a verified breakout to a new one-year high, even though the stock was trading below the session peak at the time of writing. In Stock Market Today terms, that keeps Dr. Lal Pathlabs Ltd. Share News in focus among 52 Week High Stocks and Market Movers. The next step is to examine whether the underlying fundamentals add support to the attention this price move is getting on Univest.

Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis

Metric Value
Market Capitalisation Rs 32,802.69 crore
P/E Ratio 31.07x
P/B Ratio 0.45x
ROE -2.89%
ROCE -0.26%

Dr. Lal Pathlabs Ltd. was valued at a P/E ratio of 31.07x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric Value
Sector Healthcare
Benchmark Scope same sector
Company P/E Ratio 31.07x
Benchmark Median P/E 21.13x
Benchmark Average P/E 65.01x
Benchmark P/E Range 0x to 3,374.81x
Company P/B Ratio 0.45x
Benchmark Median P/B 1.9x
Company ROE -2.89%
Benchmark Median ROE 10.92%
Company ROCE -0.26%
Benchmark Median ROCE 13.29%
Company Market Capitalisation Rs 32,802.69 crore
Benchmark Median Market Cap Rs 142.81 crore

Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare.

Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 31.07x, which is above the benchmark median of 21.13x, a difference of +47.04%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Dishman Carbogen Amcis Ltd. DCAL 2,949.87 31.07 0.45 -2.89 -0.26
Beta Drugs Ltd. BETA 2,775.9 71.31 11.28 18.65 22.17
Sai Parenteral's Ltd. SAIPARENT 2,594.65 179.52 3.32 13.9 12.97
Dr Agarwals Eye Hospital Ltd. DRAGARWQ 2,561.88 33.61 6.93 -2.6 16.92
NGL Fine-Chem Ltd. NGLFINE 2,140.53 44.41 6.49 27.9 33.91

Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 31.07x compared with the displayed peer median of 44.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 32,802.69 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Dr. Lal Pathlabs Ltd.

The stock is drawing attention because the verified data combines a fresh one-year high with distinctive valuation and sector-positioning signals. For investors following Stocks in News and Share Price Update screens, the key points are factual and measurable.

  • Fresh price event: The stock hit a new 52-week high of Rs 1,989.35 and was trading at Rs 1,963.95, up 0.75% on the day.
  • Intraday structure: The stock opened at Rs 1,950.15, the same as the day low, showing that the upward move developed after the opening trade.
  • Participation: Turnover stood at Rs 1.25 crore with volume of 6,388 shares.
  • Fundamental context: Market cap was Rs 32,802.69 crore, P/E was 31.07 and P/B was 0.45.
  • Profitability context: ROE of -2.89 and ROCE of -0.26 were below the supplied Healthcare sector medians and averages.
  • Sector positioning: The stock’s market capitalisation is far above the supplied same-sector benchmark averages and the displayed peer market caps.

About Dr. Lal Pathlabs Ltd.

The supplied data identifies Dr. Lal Pathlabs Ltd. (LALPATHLAB) as a Healthcare sector company. In this article, Univest is focusing strictly on the verified market data tied to the fresh 52-week high event rather than adding unsupplied business descriptions or segment details.

For market participants, the company is currently notable because of its Rs 32,802.69 crore market capitalisation and the fact that Dr. Lal Pathlabs Ltd. Share Price has moved to a new one-year high. Within the supplied Healthcare comparison set, that places the stock in focus not just for price action, but also for how its valuation and return ratios compare with the broader sector and selected peers.

As a result, Dr. Lal Pathlabs Ltd. Latest News in the market is being shaped primarily by the verified 52-week peak, current price behaviour and the contrast between its scale and its reported profitability ratios in this dataset.

Track Dr. Lal Pathlabs Ltd. Share Price on Univest

Use Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

On Univest, users can track Dr. Lal Pathlabs Ltd. Share Price in real time along with 52-week levels, day range, market capitalisation and other verified stock metrics. That makes it easier to follow whether the stock holds near its fresh 52-week peak or moves away from it during the session.

Univest also helps investors monitor fundamental ratios such as P/E, P/B, ROE and ROCE, while placing those numbers beside sector benchmarks and peer comparisons. For anyone following Dr. Lal Pathlabs Ltd. Share Price Today, Dr. Lal Pathlabs Ltd. Stock News and broader Stock Updates, that combined view can be useful for keeping the event in context without turning a price move into a recommendation.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is the current Dr. Lal Pathlabs Ltd. Share Price?

Ans. Dr. Lal Pathlabs Ltd. Share Price was Rs 1,963.95 at 10:17 AM IST on 12 August 2026. The stock was up Rs 14.70, or 0.75%, from the previous close of Rs 1,949.25.

Why is Dr. Lal Pathlabs Ltd. Share Price in focus today?

Ans. The stock is in focus because it touched a fresh 52-week high of Rs 1,989.35 during the session. The supplied data confirms the price event, although it does not establish a company-specific catalyst for the move.

What was the fresh 52-week high for Dr. Lal Pathlabs Ltd. today?

Ans. Dr. Lal Pathlabs Ltd. touched a fresh 52-week high of Rs 1,989.35 on 12 August 2026. At the article timestamp, the stock was trading at Rs 1,963.95, still above the previous close and in positive territory.

How much did Dr. Lal Pathlabs Ltd. rise today?

Ans. The stock rose by Rs 14.70 on the day, which translated into a gain of 0.75%. It moved from the previous close of Rs 1,949.25 to Rs 1,963.95 while also touching a new yearly high.

What does today’s price action show for Dr. Lal Pathlabs Ltd.?

Ans. The stock opened at Rs 1,950.15, which was also the day low, and later climbed to Rs 1,989.35. That pattern shows upward intraday movement after the open, followed by some cooling from the session high.

What is the market capitalisation of Dr. Lal Pathlabs Ltd.?

Ans. The company’s market capitalisation was Rs 32,802.69 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 142.81 crore and average of Rs 461.64 crore.

How is Dr. Lal Pathlabs Ltd. valued versus the Healthcare sector?

Ans. Dr. Lal Pathlabs Ltd. had a P/E of 31.07 versus the sector median of 21.13 and average of 65.01. Its P/B was 0.45, below the sector median of 1.90 and average of 2.59.

What do the ROE and ROCE figures indicate for Dr. Lal Pathlabs Ltd.?

Ans. The supplied data shows ROE of -2.89 and ROCE of -0.26. Both figures are below the Healthcare sector median ROE of 10.92 and median ROCE of 13.29, adding important context to the stock’s 52-week high.

How does Dr. Lal Pathlabs Ltd. compare with selected peers?

Ans. The stock’s P/E of 31.07 is below peers such as Beta Drugs at 71.31 and NGL Fine-Chem at 44.41. However, its ROE and ROCE are weaker than most supplied peers, while market cap is much larger.

What should investors monitor next in Dr. Lal Pathlabs Ltd. Stock News?

Ans. Investors may watch whether the stock sustains levels near its fresh 52-week high of Rs 1,989.35. They may also track valuation ratios, return metrics, sector benchmarks and peer positioning as new Dr. Lal Pathlabs Ltd. Stock News develops.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down